Why the study?
Does the use of drug-eluting stents reduce the composite of death, MI, or TVR compared to bare metal stents in patients undergoing PCI for ACS due to graft failure?
Does the use of drug-eluting stents reduce the composite of death, MI, or TVR compared to bare metal stents in patients undergoing PCI for ACS due to graft failure?
In patients presenting with ACS due to acute graft failure, long-term outcomes remain poor, and DES use was not associated with significantly improved long-term clinical outcomes compared to BMS in this nonrandomized cohort.
No takes yet. Share an insight, caveat, or question.
DES not associated with improved outcomes vs BMS in graft failure ACS; leaves open optimal stent choice pending randomized data.
Harskamp et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: